GH secretagogues including ipamorelin are sometimes discussed in the context of sleep quality
However, patients may experience some initial side effects as their bodies adjust to the medication
Consequently, research increasingly targets key pathological processes, including articular cartilage degeneration, remodeling of the subchondral bone, osteophyte formation, and synovitis (Abramoff and Caldera, 2020
Many patients also experience vomiting, particularly during the first few weeks of treatment or following dose increases
Understanding whether symptoms are primarily caused by inflammation, tendon injury, ligament damage, cartilage degeneration, or a combination of several factors is critical when exploring potential treatment options